← All stocks

LENZ Therapeutics, Inc.

LENZ No buying or selling
CIK 0001815776 #4144 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
0.9×

Evert Schimmelpennink holds only 0.9 times base salary in stock. $662.37K of shares against $690.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Evert Schimmelpennink last reported holding, valued at $8.57, the price Common Stock was last bought or sold at on the open market here, on 27 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Versant Venture Capital VI, L.P. entity
10% owner
1,814,726
$15.55M
−51.0%
Schimmelpennink Evert B.
President, CEO and Secretary
77,289
$662.37K
+71.8%
Chevallard Daniel R.
Chief Financial Officer
12,886
$110.43K
+304.2%
MCCOLLUM JAMES W
Director
10,500
$89.99K
George Jeffrey P.
Director
5,592
$47.92K
Olsson Shawn
Chief Commercial Officer
4,733
$40.56K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 28 Jun 2021